Structure-activity studies of glucagon-like peptide-1.
Kim Adelhorst(Novo Nordisk (Denmark)), Ole Kirk(University of Copenhagen), B.B. Hedegaard(Novo Nordisk (Denmark)), Lotte Bjerre Knudsen(Novo Nordisk (Denmark))
Cited by 283
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
|Journal of Clinical Investigation|2014|913